Medical Innovation Exchange

BMS-backed Arsenal Bio pulls trigger on $220M series B, touting potential fleet of gene-edited cell therapies

https://www.fiercebiotech.com/biotech/bms-backed-arsenal-bio-raises-220m-series-b-touting-potential-fleet-gene-edited-cell

Leave a Comment

Your email address will not be published.

Leave the field below empty!